
Elan Corporation
Europe, Dublin, Ireland, Dublin'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
Description
Elan Corporation, plc is a biotechnology company committs to make a difference in the lives of patients and their families.
Investor Profile
Elan Corporation has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series A rounds (top funding stages).
- Majority of deals are located in India, United Arab Emirates, United States.
- Strong thematic focus on Medical Device, Biotechnology, B2B.
Stage Focus
- Series C (25%)
- Series B (25%)
- Series A (25%)
- Series Unknown (25%)
Country Focus
- India (50%)
- United Arab Emirates (25%)
- United States (25%)
Industry Focus
- Medical Device
- Biotechnology
- B2b
- Health Care
- Marketplace
- Oncology
- Pharmaceutical
- Medical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.